ORASURE TECHNOLOGIES INC (OSUR) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, ORASURE TECHNOLOGIES INC's filing signal continuing negative.

OraSure Technologies, Inc. transforms health by decentralizing diagnostics, offering a portfolio of diagnostic products and sample management solutions. The company develops, manufactures, markets, sells, and distributes simple, easy-to-use diagnostic tests for infectious diseases like HIV, Hepatitis C, Syphilis, and Sickle Cell, as well as COVID-19. It also provides sample collection devices for DNA, RNA, and microbiome analysis, serving academic research, commercial customers, and the pharmaceutical industry. OraSure operates globally, with a significant presence in the United States and international markets, leveraging direct sales, distributors, and strategic partnerships to reach its customer base.

Revenue is primarily driven by the sale of diagnostic tests for infectious diseases and sample management solutions for genomic and microbiome analysis. The company also generates revenue from funded research and development contracts and royalty income.